Achyut Healthcare Limited (ACHYUT.BO)
INR 3.25
(4.84%)
INR 3.25
(4.84%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 4.43 Million INR | 106.0% |
| 2022 | -2.78 Million INR | -538.76% |
| 2021 | -436 Thousand INR | -443.31% |
| 2020 | 127 Thousand INR | 49.41% |
| 2019 | 85 Thousand INR | -37.96% |
| 2018 | 137 Thousand INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -861 Thousand INR | 0.0% |
| 2023 Q1 | 150 Thousand INR | 105.16% |
| 2023 Q4 | -133 Thousand INR | -100.0% |
| 2023 Q2 | 300 Thousand INR | 100.0% |
| 2023 FY | 167 Thousand INR | 106.0% |
| 2023 Q3 | -66.5 Thousand INR | -122.17% |
| 2022 Q3 | -1.37 Million INR | -2829.7% |
| 2022 Q2 | 50.5 Thousand INR | 0.0% |
| 2022 FY | -2.78 Million INR | -538.76% |
| 2022 Q1 | 50.5 Thousand INR | 102.57% |
| 2022 Q4 | -2.9 Million INR | -110.88% |
| 2021 Q1 | 835.5 Thousand INR | 0.0% |
| 2021 FY | -436 Thousand INR | -443.31% |
| 2021 Q4 | -1.96 Million INR | -105.2% |
| 2021 Q3 | -957.5 Thousand INR | -162.63% |
| 2021 Q2 | 1.52 Million INR | 82.98% |
| 2020 FY | 127 Thousand INR | 49.41% |
| 2019 FY | 85 Thousand INR | -37.96% |
| 2018 FY | 137 Thousand INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 99.923% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 99.989% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 99.951% |
| Granules India Limited | 6.81 Billion INR | 99.935% |
| Indoco Remedies Limited | 1.29 Billion INR | 99.657% |
| Ajanta Pharma Limited | 19.67 Billion INR | 99.977% |
| Alkem Laboratories Limited | 19.46 Billion INR | 99.977% |
| Alpa Laboratories Limited | 184.49 Million INR | 97.595% |
| Brooks Laboratories Limited | 14.44 Million INR | 69.266% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | 99.742% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | 99.639% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 99.993% |
| Eris Lifesciences Limited | 5.18 Billion INR | 99.914% |
| FDC Limited | 2.98 Billion INR | 99.851% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 99.932% |
| Gufic Biosciences Limited | 1.32 Billion INR | 99.666% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | 99.9% |
| Ipca Laboratories Limited | 7.98 Billion INR | 99.944% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | 99.127% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 102.921% |
| Lasa Supergenerics Limited | -458 Million INR | 100.969% |
| Laurus Labs Limited | 3.94 Billion INR | 99.888% |
| Lupin Limited | 28.04 Billion INR | 99.984% |
| Mankind Pharma Limited | 21.51 Billion INR | 99.979% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Medico Remedies Limited | 100.3 Million INR | 95.575% |
| Megasoft Limited | -121.1 Million INR | 103.665% |
| NATCO Pharma Limited | 25.96 Billion INR | 99.983% |
| Piramal Pharma Limited | 4.55 Billion INR | 99.903% |
| RPG Life Sciences Limited | 2.29 Billion INR | 99.806% |
| Sigachi Industries Limited | 1.47 Billion INR | 99.699% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 99.996% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 99.904% |
| Syncom Formulations (India) Limited | 249.25 Million INR | 98.219% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Wanbury Limited | 569.71 Million INR | 99.221% |
| Windlas Biotech Limited | 1.29 Billion INR | 99.658% |
| ZIM Laboratories Limited | 253.82 Million INR | 98.252% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 99.99% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 100.108% |
| Divi's Laboratories Limited | 33.08 Billion INR | 99.987% |
| Hester Biosciences Limited | 364.81 Million INR | 98.783% |
| Procter & Gamble Health Limited | 2.78 Billion INR | 99.841% |
| Amrutanjan Health Care Limited | 457.54 Million INR | 99.03% |
| Bal Pharma Limited | 233.9 Million INR | 98.103% |
| Strides Pharma Science Limited | 5.22 Billion INR | 99.915% |
| Venus Remedies Limited | 534.65 Million INR | 99.17% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 99.858% |
| Nectar Lifesciences Limited | 923.8 Million INR | 99.52% |
| Shilpa Medicare Limited | 1.36 Billion INR | 99.675% |
| Aarti Drugs Limited | 7.14 Billion INR | 99.938% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | 99.722% |
| Suven Life Sciences Limited | -1.22 Billion INR | 100.362% |
| Ind-Swift Limited | 1.22 Billion INR | 99.638% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 99.969% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 100.115% |
| Themis Medicare Limited | 392.58 Million INR | 98.87% |
| Hikal Limited | 32.11 Million INR | 86.179% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 99.982% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | 99.292% |
| Wockhardt Limited | -670 Million INR | 100.662% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 99.914% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | 51.062% |
| Neuland Laboratories Limited | 5.31 Billion INR | 99.917% |
| Morepen Laboratories Limited | 4.17 Billion INR | 99.894% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | 97.867% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | 83.837% |